Topic: Biotech
Dr. Francis Collins, Director of the National Institutes of Health, shows Dr. Moira Gunn just how much biotechnology is already working in health care.
The United States has been a global leader to medical technology innovation, however a changing investment environment and tougher regulatory requirements prove unique challenges for early stage innovators. From the 2011 Stanford Graduate School of Business Healthcare Summit, Stefanos Zenios, director of Stanford's GSB Program in Healthcare Innovation convenes a panel of health care investors who give those entrepreneurs starting out a full picture of the product development cycle and how to successfully raise capital.
Dr. Moira Gunn recaps the MacArthur Awards with columnist and author, David Ewing Duncan and learns how biotech and science came out in the mix.
Dr. Moira Gunn talks about the latest treatments for cancer with John Beadle, CEO of PsiOxus Therapeutics and Alnylam Pharmaceuticals President, John Maraganore.
Dr. Moira Gunn talks about a new approach to delivering immuno-suppressants to organ transplant recipients with Veloxis Pharmaceuticals CEO, Bill Polvino.
Dr. Moira Gunn catches up talks about next generation drugs and smart bacteria with University of Illinois professor, Ananda Charkarbarty.
Dr. Moria Gunn sits down with the Director of Stem Cell Biology at Viacyte, Kevin D'Mour, where they are experimenting with the natural creation of insulin using stem cells.
Dr. Moira Gunn talks about the global road map between the BioAlps in Switzerland and China's big new biotech initiative with BioAlps President, Benoit Dubuis.
Dr. Moira Gunn learns about the advances in combating Macular Degeneration using Nano Electronics from Professor and Program Leader at Bionic Vision Australia, Stan Skafidas.
Dr. Moira Gunn learns about the movement to vaccinate the children of the World against pneumonia and meningitis from the Director of the Johns-Hopkins International Vaccine Access Center, Orin Levine.
